Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06750159

The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

Based on the clue that the serum marker AKR1B10 found in the investigators' previous study can be used as an effective indicator for detecting HCC and preHCC, the role and value of AKR1B10 as a new tumor marker for evaluating the recurrence monitoring of HCC after radical surgical resection needs further study, as to provide detailed clinical research data and scientific basis for improving the survival rate of HCC patients.

Official title: Clinical Study of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

400

Start Date

2024-12-16

Completion Date

2029-12-31

Last Updated

2024-12-27

Healthy Volunteers

No

Interventions

OTHER

No intervention (observational study)

no intervention(observational study)